Related Subjects:
|Metabolic acidosis
|Lactic acidosis
|Acute Kidney Injury (AKI) / Acute Renal Failure
Alport's syndrome 🧬 is a hereditary disorder of the glomerular basement membrane (GBM), characterized by nephritis 🩸, haematuria 🚽, progressive renal failure 🩺, and high-frequency sensorineural deafness 👂. Males are more severely affected due to the typical X-linked inheritance.
About 📖
- The disease was first recognized when researchers observed that the GBM in Alport’s did not bind anti-GBM antibodies (as seen in Goodpasture’s syndrome).
- This pointed to an abnormality in Type IV collagen 🧩, the key protein in basement membranes of the kidney, ear, and eye.
Aetiology 🔬
- Most often X-linked recessive inheritance (≈80%), predominantly affecting males 👦.
- Also has autosomal recessive (AR) and autosomal dominant (AD) forms.
- COL4A5 mutation (X-linked), or mutations in COL4A3 / COL4A4 (AR/AD forms), → abnormal collagen IV → progressive GBM degeneration.
Clinical Features 🩺
- Renal: Persistent microscopic or macroscopic haematuria 🚽, progressing to end-stage renal disease (ESRD) in many patients.
- Hearing loss: Bilateral high-frequency sensorineural deafness 👂, usually emerging in adolescence.
- Ocular: Anterior lenticonus 👁️ (pathognomonic), retinal flecks, and recurrent corneal erosions.
- Family history: Often positive for kidney disease and deafness across generations.
- Female carriers 👩 may have haematuria but slower progression (due to lyonization of X-chromosome).
Investigations 🔍
- Urinalysis: Proteinuria and haematuria (dysmorphic red cells, red cell casts).
- Renal function: Rising creatinine with CKD progression.
- Renal USS: Kidneys usually normal-sized early on, later contracted.
- Genetic testing: COL4A mutations, increasingly used for diagnosis.
- Skin biopsy: May show absence of α5(IV) collagen in epidermis.
- Renal biopsy: EM shows pathognomonic GBM thickening, splitting, and lamellation (“basket-weave appearance”).
Management ⚕️
- Supportive CKD management: BP control, salt restriction, avoid nephrotoxins.
- ACE inhibitors / ARBs: Can reduce proteinuria and slow progression 🧪.
- Hearing aids & ophthalmology follow-up: For non-renal manifestations 👂👁️.
- Renal replacement therapy: Dialysis or transplant when ESRD develops. Patients are often young and otherwise fit, making them good transplant candidates.
- Post-transplant risk: 3–4% develop anti-GBM nephritis ⚠️ within the first year, as the immune system recognizes the “normal” donor GBM as foreign.
Key Clinical Pearls ✨
- Think of Alport’s in a young male with haematuria 🚽 + renal failure 🩺 + deafness 👂 ± ocular features 👁️.
- Basket-weave GBM on EM = diagnostic clue 🔬.
- Unlike Goodpasture’s, antibody staining is negative 🚫 — it’s a structural defect, not an antibody attack.